0.4749
price up icon0.04%   0.0002
pre-market  시장 영업 전:  .47   -0.0049   -1.03%
loading

Anebulo Pharmaceuticals Inc (ANEB) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-03-31 2024-12-31 2024-09-30 2024-03-31 2023-12-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
26.89%
1.8923
2.5882 2.4121 1.6643 2.7605
Interest Income/Expense
0.10
- - - -
Operating Income/Loss
26.89%
-1.8923
-2.5882 -2.4121 -1.6643 -2.7605
Nonoperating Income/Loss
72.76%
0.2162
0.1251 0.2114 0.0107 0.0431
Income/Loss From Continuing Operations Before Tax
31.95%
-1.6762
-2.463 -2.2007 -1.6535 -2.7174
Income/Loss From Continuing Operations After Tax
31.95%
-1.6762
-2.463 -2.2007 -1.6535 -2.7174
Net Income/Loss
31.95%
-1.6762
-2.463 -2.2007 -1.6535 -2.7174
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
49.86%
41.08
27.42 25.93 25.93 25.79
Diluted Average Shares
49.86%
41.08
27.42 25.93 25.93 25.79
Basic Earnings Per Share
55.56%
-0.04
-0.09 -0.08 -0.06 -0.11
Diluted Earnings Per Share
55.56%
-0.04
-0.09 -0.08 -0.06 -0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$44.80
price up icon 1.24%
$26.75
price down icon 0.19%
$100.75
price up icon 1.93%
$105.76
price down icon 3.31%
$146.17
price down icon 1.52%
biotechnology ONC
$346.42
price down icon 1.38%
자본화:     |  볼륨(24시간):